Drug pricing review board orders manufacturer to lower prices on kidney medicine

By Terry Davidson (September 28, 2022, 5:28 PM EDT) -- Canada’s drug pricing watchdog has ordered a pharmaceutical company to lower its prices on a medicine used to treat a genetic disorder that harms kidney function.  ...

Related Sections